Ameriprise Financial Inc Sage Therapeutics, Inc. Transaction History
Ameriprise Financial Inc
- $356 Billion
- Q1 2025
A detailed history of Ameriprise Financial Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 65,658 shares of SAGE stock, worth $428,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,658
Previous 125,630
47.74%
Holding current value
$428,746
Previous $682,000
23.61%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding SAGE
# of Institutions
217Shares Held
49.9MCall Options Held
220KPut Options Held
312K-
Black Rock Inc. New York, NY5.22MShares$34.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$33.2 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY4.48MShares$29.2 Million4.6% of portfolio
-
Tig Advisors, LLC New York, NY2.73MShares$17.8 Million1.36% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.09MShares$13.6 Million0.02% of portfolio
About Sage Therapeutics, Inc.
- Ticker SAGE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,422,300
- Market Cap $388M
- Description
- Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...